Gyre Therapeutics (GYRE) Accumulated Expenses (2010 - 2026)
Gyre Therapeutics' Accumulated Expenses was $18.81 million in Q2 2026, up 26.0% from $14.92 million a year earlier and up 22.0% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Gyre Therapeutics came in at $18.16 million, up 71.1% from FY2024.
- Accumulated Expenses shows a five-year compound annual growth rate of 138.6% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $10.62 million in FY2024 (-11.1%), $11.94 million in FY2023 (+28.8%), $9.26 million in FY2022 and $180,000 in FY2021 (-23.4%).
- The Q2 2026 figure marks the highest quarterly Accumulated Expenses in data going back to Q4 2010.
- Compared with a year earlier, Accumulated Expenses was higher in five of the last seven quarters, with growth averaging 28.7%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q4 2025 (growth of 71.1%); the worst was Q4 2021 (a decline of 23.4%).
- Per Business Quant data, GYRE's Accumulated Expenses in the three quarters before Q2 2026 was $15.42 million (Q1 2026), $18.16 million (Q4 2025) and $11.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Gyre Therapeutics | 753.90 Mn | 556.61 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.81 Mn |
| Mar 31, 2026 | 15.42 Mn |
| Dec 31, 2025 | 18.16 Mn |
| Sep 30, 2025 | 11.80 Mn |
| Jun 30, 2025 | 14.92 Mn |
| Mar 31, 2025 | 17.24 Mn |
| Dec 31, 2024 | 10.62 Mn |
| Sep 30, 2024 | 9.55 Mn |
| Jun 30, 2024 | 10.51 Mn |
| Mar 31, 2024 | 10.77 Mn |
| Dec 31, 2023 | 11.94 Mn |
| Jun 30, 2023 | 271,000.00 |
| Dec 31, 2022 | 9.26 Mn |
| Dec 31, 2021 | 180,000.00 |
| Dec 31, 2020 | 235,000.00 |
| Dec 31, 2019 | 250,000.00 |
| Dec 31, 2018 | 200,000.00 |
| Sep 30, 2018 | 300,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Jun 30, 2015 | 1.30 Mn |
API Access
Gyre Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();